RESEARCH AREAS

Pharmaceuticals

AEI scholars have been researching the government's role in pharmaceutical regulation, drug safety policies, prescription drugs, and the effectiveness of the Food and Drug Administration--including regulations that slow progress in drug R&D. This section of the website gathers together AEI research, books, and events focused on pharmaceuticals.

Feature: Vaccines for Swine Flu

iStockphoto/
dra_schwartz

Scott Gottlieb, M.D., has examined the swine flu vaccine shortage in light of President Obama's declaration that the outbreak is a national emergency. While the Obama administration blames the vaccine shortage on manufacturing delays, Gottlieb writes in the Wall Street Journal that "production issues only explain part of the shortfall. Also to blame are a series of policy decisions that reflect our extreme caution when it comes to these products." He outlines how U.S. policies regarding vaccines have made production slower and limited output, in contrast with European policies.

Scholars on Pharmaceuticals

Recent Publications

Why You Can't Get the Swine Flu Vaccine

By Scott Gottlieb
Wall Street Journal
Wednesday, October 28, 2009

U.S. regulations are too cautious. Europe has adopted a more sensible approach.

Counterfeit Medicines

By Roger Bate
Wellcome Trust
Monday, October 26, 2009

Myriad responses are required for all parts of the substandard drug problem.

Taxing the Sick: How "Fees" in Health Care Reform Hurt Patients

By Alex Brill
AEI Online
Wednesday, October 21, 2009

The burden of excise taxes in the America's Healthy Future Act of 2009 will largely fall on patients, meaning sick patients will be subsidizing the health care of other sick patients.

Limiting Drug Prices Means Limiting Future Cures

By John E. Calfee
Los Angeles Times
Saturday, October 10, 2009

Controls would take away the industry's incentive to develop new lifesaving medications and therapies.

» List all Recent Publications

Books

U.S. Markets for Vaccines Characteristics, Case Studies, and Controversies

By Ernst R. Berndt, Rena N. Denoncourt, Anjli C. Warner
AEI Press
(May 2009)

This volume offers a balanced and comprehensive snapshot of the changing landscape for vaccine markets.

Uncle Sam, M.D. AEI Scholars on Health Care and Pharmaceutical Reform

By Joseph Antos , Roger Bate , John E. Calfee , Scott Gottlieb , Robert B. Helms , N. Gregory Mankiw , Thomas P. Miller , Tomas J. Philipson
AEI Press
(April 2009)

This collection of essays provides an indication of the range and depth of AEI’s work in health care reform and pharmaceutical policy.

Pharmaceutical Price Regulation Public Perceptions, Economic Realities, and Empirical Evidence

By John A. Vernon, Joseph H. Golec
AEI Press
(January 2009)

This monograph demonstrates empirically how the free-market system of drug pricing is vital to the development of new breakthrough drugs.

» List all Books

Events

PAST EVENTS

Food Safety Regulations: Will More Regulation Make Us Safer?

Tuesday, October 20, 2009
01:30 PM - 04:00 PM

Will more regulations and a more centralized food safety bureaucracy make us safer? What kind of regulations and implementation mechanisms would best serve the public's desire for ensuring food safety?

The Global Impact of Fake Medicine

Wednesday, June 10, 2009
09:00 AM - 11:45 AM

What are the best ways for identifying counterfeit and substandard drugs in the field? How can consumers, regulatory bodies, and others work together to combat their deadly impact?

U.S. Markets for Vaccines: Characteristics, Case Studies, and Controversies

Friday, May 8, 2009
10:00 AM - 12:00 PM

Ernst R. Berndt and Anjli C. Warner discuss their new book, U.S. Markets for Vaccines: Characteristics, Case Studies, and Controversies.

» List all Past Events